Market Tracker

02/28 11:53am ET

Amarin Corporation PLC (NASDAQ:AMRN)

3.41
BATS BZX Real-Time Price
As of 11:49am ET
 -0.02 / -0.58%
Today’s Change
1.37
Today|||52-Week Range
3.65
+10.71%
Year-to-Date
Biotech Premarket Movers: Cempra, Novavax, Ionis
9:30am / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close3.43
Today’s open3.45
Day’s range3.40 - 3.57
Volume142,784
Average volume (3 months)2,010,419
Market cap$925.9M
Dividend yield--
Data as of 11:49am ET, 02/28/2017

Growth & Valuation

Earnings growth (last year)-159.93%
Earnings growth (this year)+33.30%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+51.17%
P/E ratioNM
Price/Sales4.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMRIAlbany Molecular Res...-0.20-1.33%
RGNXRegenxbio Inc+0.40+2.20%
BSTCBiospecifics Technol...-0.78-1.49%
MEDPMedpace Holdings Inc-7.03-19.32%
Data as of 11:52am ET, 02/28/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$81.6M
Annual profit (last year)-$148.8M
Net profit margin-182.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts